Mackay Shields LLC’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Mackay Shields LLC’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-146,800	Closed	-$587K	–	1559
2019 Q4	$587K	Buy	+146,800	New	+$690K	﹤0.01%	1145
2019 Q1	–	Sell	-48,776	Closed	-$657K	–	1478
2018 Q4	$657K	Sell	48,776 -72,274	-60%	-$1.22M	0.01%	1080
2018 Q3	$2.35M	Buy	121,050 +40,600	+50%	+$864K	0.02%	665
2018 Q2	$2.06M	Sell	80,450 -30,800	-28%	-$718K	0.01%	762
2018 Q1	$2.24M	Buy	+111,250	New	+$2.6M	0.01%	752

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Mackay Shields LLC's DPLO Position: Q1 2020 in Review

Mackay Shields LLC sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 146,800 shares — an estimated $587K sold.

Mackay Shields LLC first reported a position in DPLO in Q1 2018 and held it in 5 quarters. The position peaked at $2.35M in Q3 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Mackay Shields LLC reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Mackay Shields LLC sold 146,800 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $587K.
Mackay Shields LLC first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2018 and held it in 5 quarters.
Mackay Shields LLC's DIPLOMAT PHARMACY, INC. position peaked at $2.35M in Q3 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Mackay Shields LLC's 13F filing for Q1 2020, filed 8 May 2020.